Question 1

How many shares of CGEM does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 5.2M shares of CGEM (CULLINAN THERAPEUTICS INC).

Question 2

What is BlackRock, Inc.'s CGEM position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s CGEM position is worth $95.3M.

Question 3

Is BlackRock, Inc. buying or selling CGEM?

Accepted Answer

In 2026-Q2, BlackRock, Inc. increased their CGEM position (+17.6% change in shares).

Question 4

When did BlackRock, Inc. first buy CGEM?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in CGEM in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	5.2M	+17.6%	$95.3M	0.0%	$18.21	35
2026-Q1	Increased	4.4M	+1.1%	$63.2M	0.0%	$15.73	30
2025-Q4	Increased	4.4M	+5.5%	$45.5M	0.0%	$9.92	31
2025-Q3	Decreased	4.2M	-1.1%	$24.7M	0.0%	$5.97	0
2025-Q2	Decreased	4.2M	-0.1%	$31.8M	0.0%	$7.76	0
2025-Q1	Decreased	4.2M	-3.4%	$32M	0.0%	$8.02	0
2024-Q4	New	4.4M	-	$53.2M	0.0%	$12.20	41

CGEM7 quarters

CGEM
7 quarters